Veerhealth Care

56
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE882C01035
  • NSEID: NIYATILEAS
  • BSEID: 511523
INR
49.67
-0.29 (-0.58%)
BSENSE

Sep 22, 03:30 PM

BSE+NSE Vol: 1.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 92.60% vs 27.55% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 219.47% vs 26.06% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 52.42% vs 3,371.82% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 39.00% vs -3.63% in Mar 2025

Compare Profit and Loss Results of Veerhealth Care
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
32.00
10.00
22.00
220.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
32.00
10.00
22.00
220.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
0.00
-2.00
0%
Raw Materials Consumed
26.00
11.00
15.00
136.36%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
5.00
-4.00
-80.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
30.00
24.00
6.00
25.00%
Operating Profit (PBDIT) excl Other Income
2.00
-14.00
16.00
114.29%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
3.00
-13.00
16.00
123.08%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
2.00
-16.00
18.00
112.50%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
1.00
-17.00
18.00
105.88%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
-13.00
14.00
107.69%
Provision for Tax
0.00
-3.00
3.00
100.00%
Profit After Tax
0.00
-10.00
10.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
-22.00
23.00
104.55%
Profit Available for appropriations
1.00
-32.00
33.00
103.12%
Appropriations
1.00
-32.00
33.00
103.12%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.27
-2.95
3.22
109.15%
Profit And Loss - Net Sales
Net Sales 32.48 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 92.60% vs 27.55% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.46 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 219.47% vs 26.06% in Mar 2025

Profit And Loss - Interest
Interest 0.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 52.42% vs 3,371.82% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 0.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 39.00% vs -3.63% in Mar 2025